Entrada Therapeutics, Inc.TRDANASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$1.48
Net Income/Share$-2.50
Operating CF/Share$-3.09
Free CF/Share$-3.13
Cash/Share$7.88
Book Value/Share$8.22
Tangible Book/Share$8.22
Equity/Share$8.22
Interest Debt/Share$1.26
CapEx/Share$0.05
Dividend/Share$0.00
Valuation
Market Cap$454.11M
Enterprise Value$413.22M
P/E Ratio-4.76P/S Ratio7.38P/OCF Ratio-3.85
P/FCF Ratio-3.50
P/B Ratio1.45P/TB Ratio1.45
EV/Sales6.72EV/EBITDA-3.63
Graham Valuation
Graham Number--
Graham Net-Net$6.20
Profitability
Earnings Yield-21.00%FCF Yield-28.58%ROE-26.42%ROIC-30.61%Return on Tangible Assets-25.06%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-1.47%
CapEx/Revenue3.06%
CapEx/Depreciation0.45
SBC/Revenue24.11%
SG&A/Revenue67.23%
R&D/Revenue230.36%
Liquidity & Solvency
Debt/Equity0.15Debt/Assets0.13Debt/Market Cap0.12
Net Debt/EBITDA0.36
Current Ratio14.08Interest Coverage0.00xIncome Quality1.24Efficiency
Days Sales Outstanding19 days
Days Payables Outstanding30 days
Days Inventory0 days
Receivables Turnover19.25x
Payables Turnover12.12x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$340.72M
Working Capital$314.24M
Invested Capital$384.77M
Intangibles/Assets0.00%